Advanced searches left 3/3

Lung Cancer - Crossref

Summarized by Plex Scholar
Last Updated: 15 June 2022

* If you want to update the article please login/register

KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer

"We show that EP300 mutants lacking an acetyltransferase domain promote tumor formation in mouse models of SCLC. " However, unexpectedly good Ep300 knockout stops SCLC growth and proliferation. In EP300 KIX, Ala 627's findings in EP300 KIX have a higher protein-binding affinity than Asp 647 at the same position in CREBBP KIX, explaining the selectivity of KIX-binding partners for EP300. SCLC development in mice and cell growth is limited by KIX-mediated interactions, according to a blockade of KIX-mediated interactions. This report delves into the EP300 role for EP300 in SCLC and the EP300 KIX domain's unique vulnerability for therapeutic intervention. ".

Source link: https://doi.org/10.1126/sciadv.abl4618


Alteration in subclinical lesions of epidermal growth factor receptor-mutated non-small cell lung cancer transplanted tumors in nude mice suggest the delineation of clinical targets volume Changes of subclinical lesions after EGFR-TKI treatment

"Abstract Objective": After EGFR-TKI treatment, subcutaneous xenograft tumors in nude mice increased. Methods In control and treatment groups, human lung adenocarcinoma cell lines were subcutaneously transplanted on the right hind legs of the nude mice's right hind legs. The subcutaneous lesions were also observed in the Gefitinib treatment group, just after tumor shrinkage. The transplanted tumor's long length in the T group dropped to 15, 10, 5, and 0mm, the first infiltration range being 8. 77, 2. 13, and 0. 11mm. the transplanted tumor's border was expanded 8. 99mm to include 95% of subcutaneous lesions. The extended range in T group was significantly larger than group C. After gefitinib therapy, the lesion narrowed, but it was wider than that of a subcutaneous lesion without therapy. ".

Source link: https://doi.org/10.21203/rs.3.rs-1737790/v1


Dose Analysis of Boron Neutron Capture Therapy (BNCT) Treatment for Lung Cancer Based on Particle and Heavy Ion Transport Code System (PHITS)

"The aim of this research was to determine the effect of boron concentration on lung cancer treatment's total dose rate and to determine the effect of boron concentration on lung cancer treatment length and length. " The greater the amount of boron concentration was administered, the higher the incidence of total dose of lung cancer treatment, according to the study, the earlier the irradiation time for each variation of boron concentration was 3179 s, 29240 s, 20633 s, and 17996 s.

Source link: https://doi.org/10.29037/ajstd.545


Dysbiosis of the Gut Microbiome Is Associated With Histopathology of Lung Cancer

"However, studies comparing the biome of lung cancer in different histopathology types of lung cancer remain scant. " Our review revealed that classified cancer patients had distinct intestinal flora characteristics, reduced density, and flora diversity in comparison to healthy individuals. Patients in the AAH/IS group and HP group had remarkably similar flora structure to those in the IA and MIA groups. A decrease in short-chain fatty acids production and anti-inflammatory bacteria in lung cancer patients compared to healthy ones, while some pathogenic bacteria, such as proinflammatory or tumor-promoting bacteria, were more prevalent in lung cancer patients. These results include new biomarkers for the diagnosis and prognostic evaluation of lung cancer, as well as the development of novel targeted therapeutic strategies for lung cancer prevention and treatment.

Source link: https://doi.org/10.3389/fmicb.2022.918823


Lung Cancer Detection using Supervised Machine Learning Techniques

"Lung cancer is the most common cause of death in both male and female around the world in recent years. " Although lung cancer prevention is impossible, early detection of lung cancer can effectively treat lung cancer at an early age. If lung cancer is detected early, the likelihood of a patient's survival rate is increasing. The primary aim of this research is to determine the success of machine learning algorithms in detecting lung cancer at an early age. The Random forest model produces a high result, with a 99. 99% accuracy rate" when compared to other supervised machine learning algorithms.

Source link: https://doi.org/10.54692/lgurjcsit.2022.0601276


Long-Term Outcomes of Robotic-Assisted, Video-Assisted and Open Surgery in Non-Small Cell Lung Cancer: A Matched Analysis

"Introduction: "This report shows a comparison of stage I non-small cell lung cancer patients who were exposed to either robotic-assisted thoracic surgery, video-assisted thoracic surgery, or open thoracotomy, with the aim of determining differences between these three treatments in terms of oncological outcomes. Conclusions: No differences were found in OS and cancer-specific survival for stage I NSCLC patients, including local recurrences, in particular local recurrences, as well as in RATS and open lobectomy.

Source link: https://doi.org/10.3390/jcm11123363


A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population

"Background" is the background of this research's attempt to create and validate a radiomics nomogram by integrating the radiomics elements extracted from the CT images and established clinical characteristics in order to determine the overall survival of patients with non-small cell lung cancer. The radiomics signature and clinical variables that were derived from clinical findings were combined to create the prognosis prediction. Both in the training cohort and the validation cohort showed a higher prognostic result than the clinical nomogram combined with six clinical variables. Conclusion The established radiomics nomogram may be a noninvasive predictor of personalized survival prognosis determination in patients with NSCLC. The radiomics signature derived from CT images could help clinicians in decision-making and hold the promise to be implemented in both patient care and clinical trials.

Source link: https://doi.org/10.3389/fonc.2022.816766


Rare case: paraneoplastic syndrome affecting peripheral nerves, associated with anti-collapsin-response mediator protein-5 (anti-CRMP5) antibodies, as early manifestation of small cell lung cancer confined to a solitary lymph node without evidence of lung mass on routine CT thorax

"A 69-year-old woman with a history of gradually worsening upper and lower leg limb weakness, leading to reduced functional status. " She was working with the respiratory team for the surveillance of a hamartoma in left lower lobe. Anti-HU and anti-CV2 antibodies were found positive in serum, as well as anti-virus and anti-CV2 antibodies. Surreal nerve biopsy sparked suspicion of paraneoplastic disease, leading to a suspicion of paraneoplastic disease. A primary neoplastic source was found after a CT thorax abdomen and pelvis was obtained to locate a primary neoplastic source, but no lesion was found other than the previously reported hamartoma in the left lower lobe. A single fluorodeoxyglucose was identified by a single fluorodeoxyglucose test either in the mid oesophagus or in the left oesophageal region below the left main bronchus. On histological examination, Bronchoscopy/endobronchial ultrasound-guided lymph node biopsy revealed small cell lung carcinoma in small cell lung carcinoma. Her symptoms haven't resolved, but not worsening any more, and she's getting physiotherapy to regain leg function. ".

Source link: https://doi.org/10.1136/bcr-2019-232656


Rapidly Growing Intra-Cardiac Mass Mimicking a Local Recurrence of Lung Cancer or a Thrombus in the Left Atrium

"We had to investigate some troubling concerns with the left atrial mass, and whether cerebral recurrence of cerebral disorders was due to the thrombotic material in the left atrium or locally recurrent lung cancer from the stump margin of the previously surgical left superior pulmonary vein. " "We show a case with a rapidly growing left atrial myxoma with a growth rate of 12. 60 mm/month rather than a thrombus or local recurrence of tumor under non-VKA oral antagonists' medications.

Source link: https://doi.org/10.1532/hsf.2479


Expression of Zyxin in Non-Small Cell Lung Cancer—A Preliminary Study

"Background: In several cancer types, the possibility of zyxin involvement in carcinogenesis has been explored. " Since lung cancer is one of the most commonly diagnosed carcinomas, this study sought to determine the localization and expression of ZYX in NSCLC and then compare the results to the clinicopathological findings. The findings revealed lower ZYX concentrations in NSCLC cells relative to control tissues, which were lower than control tissues. Also in cancer cells, lower ZYX levels were observed in tumor cells compared to control cells in the NSCLC model, according to the assays.

Source link: https://doi.org/10.3390/biom12060827

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions